Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients

Inclusion criteria: * Patients with histologically or cytologically confirmed diagnosis of extensive disease small-cell lung cancer (ED SCLC) * Age ≥ 18 years * WHO Performance Status Grade ≤ 1 (ie. ability to perform normal daily functions) * Adequate bone marrow, liver and renal function Exclusion criteria: * Chronic steroid treatment * Prior treatment with chemotherapy for advanced lung cancer * Prior treatment with mTOR inhibitors * Active bleeding conditions, skin conditions, gastrointestinal disorders, mouth ulcers, eye conditions, chronic liver or kidney disorders, uncontrolled diabetes, infections or other severe medical conditions * Symptomatic or uncontrolled brain metastases * Other cancers within the past 5 years * Pregnant or breastfeeding women Other protocol-defined inclusion/exclusion criteria may apply.